Retatrutide is an investigational medication being evaluated for its potential role in weight management, with research focusing on its effects on multiple hormone pathways involved in appetite and energy regulation.
It is important to understand that Retatrutide is not currently approved by the FDA for general clinical use. Ongoing clinical trials continue to evaluate its safety and effectiveness. During your consultation, our provider can discuss current medical weight management options and explain how investigational therapies are being studied in comparison to currently approved treatment options.
Clinical studies are currently evaluating how Retatrutide may affect weight and metabolic processes. Areas of ongoing research include:
If you are ready to take a more structured and medically guided approach to weight management, our team is available to guide you through the next steps.
Contact Purefico Medspa and Longevity Center in Cornelius, NC, to schedule your consultation and explore personalized options designed to support your health goals.
Retatrutide is an investigational medication and is not currently approved by the U.S. Food and Drug Administration for general clinical use. The information provided on this page is for educational purposes only and should not be interpreted as medical advice or a guarantee of treatment outcomes.
All medical services and recommendations are provided based on individual evaluation by a licensed healthcare provider. Results vary from patient to patient. No investigational medications are offered as standard treatment at this clinic.